PET reveals link between hereditary personality trait and brain endorphine system
Researchers using PET have validated a theory that individual personality traits—particularly reward dependency—are connected to brain chemistry, which has implications for better understanding and treatment of substance abuse and other addictive behaviors. The study appears in the current issue in the Journal of Nuclear Medicine.
In a study to identify biochemical correlates of personality traits in healthy humans, researchers focused their investigation for the first time on the role of the brain’s opioidergic (or endorphine) system—specifically, the connection between an individual’s level of reward expectancy and the brain’s ability to transmit naturally occurring opiates.
The study included 23 males with no history of substance abuse, who were administered Fluoro-ethyl-diprenorphine (a radiolabeled chemical that binds readily to the brain’s naturally occurring opiate system), and then underwent a PET scan, the authors wrote.
The investigators compared scans to the results of each participant’s Cloninger temperament and character inventory, and assessed a questionnaire that human personality based on four dimensions: novelty seeking, harm avoidance, reward dependence and persistence.
The comparison revealed that the binding to opiate receptors in the ventral striatum—an area of the brain known to be a central part of the reward system—correlated narrowly to the individual degree of reward dependence. The participants, who skewed toward a high need to feel rewarded by approval, were also those with the highest uptake of opiates, or endorphins, in the reward system, according to the reserachers.
“Our main finding was that reward dependence is the only personality dimension correlated with opiate receptor binding, and that positive correlation was restricted to the ventral striatum, which is considered the key area of the human reward system and of the development of addictive behavior,” said Peter Bartenstein, MD, professor of nuclear medicine at Ludwig Maximilians-University in Munich, Germany. “This correlation means that people with high reward dependence have a high concentration of opiate receptors available in that area, while people with low dependence have fewer opiate receptors.”
According to the researchers, the biological purpose of the human reward system is to initiate behavior essential for the maintenance of the individual (i.e., food intake) or the species (i.e., reproduction). Therefore, food or sexual stimuli lead to an opioid-modulated dopamine release in core structures of the reward system and subsequently induce the sensation of craving. Modern addiction research maintains that genetic or acquired abuses of the reward system are the central basis for the development of addictive behavior.
The authors said that the latest finding suggests that individuals suffering from a relative endorphine deficit in their reward system show increased reward dependence and are probably more at risk for developing addictions.
“Understanding the central role of neurotransmission processes in certain brain structures for the expression of psychologically defined constructs such as personality will make a great difference in the future of medicine,” said Mathias Schreckenberger, MD, professor of nuclear medicine at Johannes Gutenberg-University in Mainz, Germany.
The researchers said that they foresee PET becoming the preferred imaging method for individualized therapy in a range of disorders caused by addictive behavior—such as drug abuse or pathological gambling—because it is the only method able to show specific local changes in different neurotransmitter systems (opiate, dopamine and serotonine) involved in addiction.
In a study to identify biochemical correlates of personality traits in healthy humans, researchers focused their investigation for the first time on the role of the brain’s opioidergic (or endorphine) system—specifically, the connection between an individual’s level of reward expectancy and the brain’s ability to transmit naturally occurring opiates.
The study included 23 males with no history of substance abuse, who were administered Fluoro-ethyl-diprenorphine (a radiolabeled chemical that binds readily to the brain’s naturally occurring opiate system), and then underwent a PET scan, the authors wrote.
The investigators compared scans to the results of each participant’s Cloninger temperament and character inventory, and assessed a questionnaire that human personality based on four dimensions: novelty seeking, harm avoidance, reward dependence and persistence.
The comparison revealed that the binding to opiate receptors in the ventral striatum—an area of the brain known to be a central part of the reward system—correlated narrowly to the individual degree of reward dependence. The participants, who skewed toward a high need to feel rewarded by approval, were also those with the highest uptake of opiates, or endorphins, in the reward system, according to the reserachers.
“Our main finding was that reward dependence is the only personality dimension correlated with opiate receptor binding, and that positive correlation was restricted to the ventral striatum, which is considered the key area of the human reward system and of the development of addictive behavior,” said Peter Bartenstein, MD, professor of nuclear medicine at Ludwig Maximilians-University in Munich, Germany. “This correlation means that people with high reward dependence have a high concentration of opiate receptors available in that area, while people with low dependence have fewer opiate receptors.”
According to the researchers, the biological purpose of the human reward system is to initiate behavior essential for the maintenance of the individual (i.e., food intake) or the species (i.e., reproduction). Therefore, food or sexual stimuli lead to an opioid-modulated dopamine release in core structures of the reward system and subsequently induce the sensation of craving. Modern addiction research maintains that genetic or acquired abuses of the reward system are the central basis for the development of addictive behavior.
The authors said that the latest finding suggests that individuals suffering from a relative endorphine deficit in their reward system show increased reward dependence and are probably more at risk for developing addictions.
“Understanding the central role of neurotransmission processes in certain brain structures for the expression of psychologically defined constructs such as personality will make a great difference in the future of medicine,” said Mathias Schreckenberger, MD, professor of nuclear medicine at Johannes Gutenberg-University in Mainz, Germany.
The researchers said that they foresee PET becoming the preferred imaging method for individualized therapy in a range of disorders caused by addictive behavior—such as drug abuse or pathological gambling—because it is the only method able to show specific local changes in different neurotransmitter systems (opiate, dopamine and serotonine) involved in addiction.